# US 2002/0059663 A1 · Expressed sequences of arabidopsis thaliana

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0059663 A1
- Document ID: US20020059663A1
- Status: Published application
- Kind: A1
- Application number: 09/770,149
- Filed: 2001-01-26
- Published: 2002-05-16
- Earliest claimed: 2000-01-27
- Inventors: Jorn Gorlach; Yong-Qiang An; Carol M. Hamilton; Jennifer L. Price; Tracy M. Raines; Yang Yu; Joshua G. Rameaka; Amy Page; Abraham V. Mathew; Brooke L. Ledford; Jeffrey P. Woessner; William David Haas; Carlos A. Garcia; Maja Kricker; Ted Slater; Keith R. Davis; Keith Allen; Neil Hoffman; Patrick Hurban
- Web page: https://patentgrep.com/patent/US20020059663A1

## CPC

- C07K 14/415: from plants
- C12N 15/8242: {with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits}
- C12N 15/8261: {with agronomic (input) traits, e.g. crop yield}
- Y02A 40/146: Genetically Modified [GMO] plants, e.g. transgenic plants
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Isolated nucleotide compositions and sequences are provided for Arabidopsis thaliana genes. The nucleic acid compositions find use in identifying homologous or related genes; in producing compositions that modulate the expression or function of its encoded protein, mapping functional regions of the protein; and in studying associated physiological pathways. The genetic sequences may also be used for the genetic manipulation of cells, particularly of plant cells. The encoded gene products and modified organisms are useful for screening of biologically active agents, e.g. fungicides, insecticides, etc.; for elucidating biochemical pathways; and the like.

## Claims

### Claim 1

A nucleic acid comprising a sequence capable of hybridizing under stringent conditions to a sequence set forth in SEQ ID NO:1 to 999, or a fragment thereof.

### Claim 2 (depends on 1)

A vector comprising the nucleic acid of claim 1.

### Claim 3 (depends on 2)

The vector of claim 2, wherein said vector comprises regulatory elements for expression, operably linked to said sequence.

### Claim 4 (depends on 1)

A polypeptide encoded by the nucleic acid of claim 1.

### Claim 5

A nucleic acid comprising: an ATG start codon; an optional intervening sequence; a coding sequence capable of hybridizing under stringent conditions as set forth in SEQ ID NO:1 to 999; and an optional terminal sequence, wherein at least one of said optional sequences is present, and wherein:
ATG is a start codon;
said intervening sequence comprises one or more codons in-frame with said coding sequence, and is free of in-frame stop codons; and
said terminal sequence comprises one or more codons in-frame with said coding sequence, and a terminal stop codon.

### Claim 6 (depends on 5)

The nucleic acid of claim 5, wherein said nucleic acid is expressed in Arabidopsis thaliana.

### Claim 7 (depends on 5)

The nucleic acid of claim 5, wherein said nucleic acid encodes a plant protein.

### Claim 8 (depends on 7)

The nucleic acid of claim 7, wherein said plant is a dicot.

### Claim 9 (depends on 8)

The nucleic acid of claim 8, wherein said dicot is Arabidopsis thaliana.

### Claim 10 (depends on 7)

The nucleic acid of claim 7, wherein said plant protein is a naturally occurring plant protein.

### Claim 11 (depends on 7)

The nucleic acid of claim 7, wherein said plant protein is a genetically modified plant protein.

### Claim 12 (depends on 5)

The nucleic acid of claim 5, wherein said nucleic acid encodes a fusion protein comprising an Arabidopsis thaliana protein and a fusion partner.

### Claim 13 (depends on 5)

The nucleic acid of claim 5, wherein said nucleic acid encodes a fusion protein comprising of plant protein and a fusion partner.

### Claim 14

A transgenic plant comprising an exogenous nucleic acid, wherein said nucleic acid comprises transcription regulatory sequences operably linked to a sequence capable of hybridizing under stringent conditions to a sequence set forth in SEQ ID NO:1 to 999 or a fragment thereof, wherein said sequence is expressed in cells of said plant.

### Claim 15 (depends on 14)

The transgenic plant of claim 14, wherein said plant is regenerated from transformed embryogenic tissue.

### Claim 16 (depends on 14)

The transgenic plant of claim 14, wherein said plant is a progeny of one or more subsequent generations from transformed embryogenic tissue.

### Claim 17 (depends on 14)

The transgenic plant of claim 14, wherein said sequence capable of hybridizing under stringent conditions to a sequence set forth in SEQ ID NO:1 to 999 encodes a plant protein.

### Claim 18 (depends on 14)

The transgenic plant of claim 14, wherein said plant protein is a naturally occurring plant protein.

### Claim 19 (depends on 14)

The transgenic plant of claim 14, wherein said plant protein is a genetically altered plant protein.

### Claim 20 (depends on 14)

The transgenic plant of claim 14, wherein said sequence expressed in cells of said plant is an anti-sense sequence.

### Claim 21 (depends on 14)

The transgenic plant of claim 14, wherein said sequence expressed in cells of said plant is a sense sequence.

### Claim 22 (depends on 14)

The transgenic plant of claim 14, wherein said sequence is selectively expressed in specific tissues of said plant.

### Claim 23 (depends on 14)

The transgenic plant of claim 14, wherein said specific tissue is selected from the group consisting of leaves, stems, roots, flowers, tissues, epicotyls, meristems, hypocotyls, cotyledons, pollen, ovaries, cells, and protoplasts.

### Claim 24

A genetically modified cell, comprising an exogenous nucleic acid, wherein said nucleic acid comprises transcription regulatory sequences operably linked to a sequence capable of hybridizing under stringent conditions to a sequence set forth in SEQ ID NO:1 to 999, wherein said sequence is expressed in cells of said plant.

### Claim 25 (depends on 4, 14, 24)

A method of screening a candidate agent for its biological effect; the method comprising:
combining said candidate agent with one of:
a genetically modified cell according to claim 24, a transgenic plant according to claim 14, or a polypeptide according to claim 4; and
determining the effect of said candidate agent on said plant, cell or polypeptide.

### Claim 26

A nucleic acid array comprising at least one nucleic acid as set forth in SEQ ID NO:1-999 stably bound to a solid support.

### Claim 27

An array comprising at least one polypeptide encoded by a nucleic acid as set forth in SEQ ID NO:1-999, stably bound to a solid support.
